Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin C. Tang currently holds 4,344,800 shares of Ardea Biosciences, Inc./DE (RDEA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin C. Tang has been a net buyer of RDEA stock. They have purchased $51.4M and sold $834.8K worth of shares.
Kevin C. Tang's most recent insider trade was on May 12, 2023, when they purchased 6,183 shares at $1.95 per share.
Kevin C. Tang serves as Executive at Ardea Biosciences, Inc./DE (RDEA). They have executed 133 insider transactions totaling $52.2M over their tenure at the company.
Kevin C. Tang holds the position of Executive at Ardea Biosciences, Inc./DE, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kevin C. Tang has shown a buying trading pattern, with $51.4M in total purchases and $834.8K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Kevin C. Tang was on May 3, 2023, when they sold $97.4M worth of JNCE shares. This transaction involved 10,000 shares at $9737.70 per share.
Kevin C. Tang currently owns 4,344,800 shares of Ardea Biosciences, Inc./DE (RDEA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin C. Tang's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin C. Tang has 133 Form 4 filings on record as an insider at Ardea Biosciences, Inc./DE.
Set alerts for Kevin C. Tang and 40,000+ other insiders.